Search

A combination of immunotherapy agents that encourages some immune cells to eat cancer cells and alert others to attack tumors put mice with a deadly type of brain cancer called glioblastoma into long-term remission

Scientists at Children’s Medical Center Research Institute at UT Southwestern (CRI) have discovered that large pieces of DNA can transfer directly between human cells, and the DNA can persist and change how the recipient cell functions.

UT Southwestern researchers have uncovered how cells in general modulate their energy consumption based on their surroundings.

When activated in ovarian cancer cells, the receptor for the body’s primary stress hormone alters the tumor environment in ways that blunt immune response, according to new research led by UT Southwestern Medical Center.

For decades, lung cancer has been one of medicine’s toughest opponents. Radiation therapy can slow the disease, but delivering curative doses without harming nearby organs, such as the heart and esophagus has remained out of reach.

When he was just 6 months old, Todd Roberts moved with his family from Houston to Brazil to support his scientist father’s research on malaria and other mosquito-borne diseases. There, he simultaneously learned Brazilian Portuguese and English, becoming the most fluent bilingual speaker in his household.

SoRelle, Park contribute to research of severity of cancer immunotherapy side effects linked to genetics Published on: May 06, 2026 Dr. Jeff SoRelle Dr. Jason Park Severity of cancer immunotherapy side effects linked to genetics Back-to top

MusiQ Bio, a biotech startup created to advance an anticancer technology developed at UT Southwestern Medical Center, has been awarded a $2.59 million grant from the Cancer Prevention and Research Institute of Texas (CPRIT).

Since launching in April, the North Texas Alzheimer’s Disease Research Center (NT-ADRC) based at UT Southwestern Medical Center has quickly established the foundation needed to support cutting-edge research into Alzheimer’s and related dementias.

President's Proclamation: Starting September 21, 2025, U.S. employers must pay a $100,000 fee per worker to bring an H-1B employee from abroad, unless an exception applies.